An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis
Clinical trial NCT06089668 · COMPLETED
Trial details
- NCT number
- NCT06089668
- Sponsor
- AN2 Therapeutics, Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-10-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.